Erratum: Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma (Cancer Cell (2020) 38(4) (500–515.e3), (S1535610820304165), (10.1016/j.ccell.2020.08.005))

Catherine S. Grasso; Jennifer Tsoi; Mykola Onyshchenko; Gabriel Abril-Rodriguez; Petra Ross-Macdonald; Megan Wind-Rotolo; Ameya Champhekar; Egmidio Medina; Davis Y. Torrejon; Daniel Sanghoon Shin; Phuong Tran; Yeon Joo Kim; Cristina Puig-Saus; Katie Campbell; Agustin Vega-Crespo; Michael Quist; Christophe Martignier; Jason J. Luke; Jedd D. Wolchok; Douglas B. Johnson; Bartosz Chmielowski; F. Stephen Hodi; Shailender Bhatia; William Sharfman; Walter J. Urba; Craig L. Slingluff; Adi Diab; John B.A.G. Haanen; Salvador Martin Algarra; Drew M. Pardoll; Valsamo Anagnostou; Suzanne L. Topalian; Victor E. Velculescu; Daniel E. Speiser; Anusha Kalbasi; Antoni Ribas

doi:10.1016/j.ccell.2020.11.015

Erratum: Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma (Cancer Cell (2020) 38(4) (500–515.e3), (S1535610820304165), (10.1016/j.ccell.2020.08.005))

Catherine S. Grasso, Jennifer Tsoi, Mykola Onyshchenko, Gabriel Abril-Rodriguez, Petra Ross-Macdonald, Megan Wind-Rotolo, Ameya Champhekar, Egmidio Medina, Davis Y. Torrejon, Daniel Sanghoon Shin, Phuong Tran, Yeon Joo Kim, Cristina Puig-Saus, Katie Campbell, Agustin Vega-Crespo, Michael Quist, Christophe Martignier, Jason J. Luke, Jedd D. Wolchok, Douglas B. JohnsonBartosz Chmielowski, F. Stephen Hodi, Shailender Bhatia, William Sharfman, Walter J. Urba, Craig L. Slingluff, Adi Diab, John B.A.G. Haanen, Salvador Martin Algarra, Drew M. Pardoll, Valsamo Anagnostou, Suzanne L. Topalian, Victor E. Velculescu, Daniel E. Speiser, Anusha Kalbasi, Antoni Ribas

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

(Cancer Cell 38, 500–515.e1–e3; October 12, 2020) In this article, we report that T cell-induced interferon-γ correlates to response to immune checkpoint blockade therapy in melanoma patients. We would like to provide two additional supplemental tables. Table S1 details unidentifiable demographic information of patients to facilitate the re-analysis of the data based on specific patient characteristics or subgroups of melanomas. Table S2 contains the 549 interferon-γ-induced genes in melanoma cell lines that are mentioned in the article. These supplemental tables are now cited in the online version of the article and are provided with this article online.

Original language	English (US)
Pages (from-to)	122
Number of pages	1
Journal	Cancer cell
Volume	39
Issue number	1
DOIs	https://doi.org/10.1016/j.ccell.2020.11.015
State	Published - Jan 11 2021

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/j.ccell.2020.11.015

Fingerprint

Dive into the research topics of 'Erratum: Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma (Cancer Cell (2020) 38(4) (500–515.e3), (S1535610820304165), (10.1016/j.ccell.2020.08.005))'. Together they form a unique fingerprint.

Cite this

Grasso, C. S., Tsoi, J., Onyshchenko, M., Abril-Rodriguez, G., Ross-Macdonald, P., Wind-Rotolo, M., Champhekar, A., Medina, E., Torrejon, D. Y., Shin, D. S., Tran, P., Kim, Y. J., Puig-Saus, C., Campbell, K., Vega-Crespo, A., Quist, M., Martignier, C., Luke, J. J., Wolchok, J. D., ... Ribas, A. (2021). Erratum: Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma (Cancer Cell (2020) 38(4) (500–515.e3), (S1535610820304165), (10.1016/j.ccell.2020.08.005)). Cancer cell, 39(1), 122. https://doi.org/10.1016/j.ccell.2020.11.015

Erratum: Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma (Cancer Cell (2020) 38(4) (500–515.e3), (S1535610820304165), (10.1016/j.ccell.2020.08.005)). / Grasso, Catherine S.; Tsoi, Jennifer; Onyshchenko, Mykola et al.
In: Cancer cell, Vol. 39, No. 1, 11.01.2021, p. 122.

Research output: Contribution to journal › Comment/debate › peer-review

Grasso, CS, Tsoi, J, Onyshchenko, M, Abril-Rodriguez, G, Ross-Macdonald, P, Wind-Rotolo, M, Champhekar, A, Medina, E, Torrejon, DY, Shin, DS, Tran, P, Kim, YJ, Puig-Saus, C, Campbell, K, Vega-Crespo, A, Quist, M, Martignier, C, Luke, JJ, Wolchok, JD, Johnson, DB, Chmielowski, B, Hodi, FS, Bhatia, S, Sharfman, W, Urba, WJ, Slingluff, CL, Diab, A, Haanen, JBAG, Algarra, SM, Pardoll, DM , Anagnostou, V , Topalian, SL , Velculescu, VE, Speiser, DE, Kalbasi, A & Ribas, A 2021, 'Erratum: Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma (Cancer Cell (2020) 38(4) (500–515.e3), (S1535610820304165), (10.1016/j.ccell.2020.08.005))', Cancer cell, vol. 39, no. 1, pp. 122. https://doi.org/10.1016/j.ccell.2020.11.015

Grasso CS, Tsoi J, Onyshchenko M, Abril-Rodriguez G, Ross-Macdonald P, Wind-Rotolo M et al. Erratum: Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma (Cancer Cell (2020) 38(4) (500–515.e3), (S1535610820304165), (10.1016/j.ccell.2020.08.005)). Cancer cell. 2021 Jan 11;39(1):122. doi: 10.1016/j.ccell.2020.11.015

@article{24cf1098599b4db39b80e0054fd1b65d,

title = "Erratum: Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma (Cancer Cell (2020) 38(4) (500–515.e3), (S1535610820304165), (10.1016/j.ccell.2020.08.005))",

abstract = "(Cancer Cell 38, 500–515.e1–e3; October 12, 2020) In this article, we report that T cell-induced interferon-γ correlates to response to immune checkpoint blockade therapy in melanoma patients. We would like to provide two additional supplemental tables. Table S1 details unidentifiable demographic information of patients to facilitate the re-analysis of the data based on specific patient characteristics or subgroups of melanomas. Table S2 contains the 549 interferon-γ-induced genes in melanoma cell lines that are mentioned in the article. These supplemental tables are now cited in the online version of the article and are provided with this article online.",

author = "Grasso, {Catherine S.} and Jennifer Tsoi and Mykola Onyshchenko and Gabriel Abril-Rodriguez and Petra Ross-Macdonald and Megan Wind-Rotolo and Ameya Champhekar and Egmidio Medina and Torrejon, {Davis Y.} and Shin, {Daniel Sanghoon} and Phuong Tran and Kim, {Yeon Joo} and Cristina Puig-Saus and Katie Campbell and Agustin Vega-Crespo and Michael Quist and Christophe Martignier and Luke, {Jason J.} and Wolchok, {Jedd D.} and Johnson, {Douglas B.} and Bartosz Chmielowski and Hodi, {F. Stephen} and Shailender Bhatia and William Sharfman and Urba, {Walter J.} and Slingluff, {Craig L.} and Adi Diab and Haanen, {John B.A.G.} and Algarra, {Salvador Martin} and Pardoll, {Drew M.} and Valsamo Anagnostou and Topalian, {Suzanne L.} and Velculescu, {Victor E.} and Speiser, {Daniel E.} and Anusha Kalbasi and Antoni Ribas",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2021",

month = jan,

day = "11",

doi = "10.1016/j.ccell.2020.11.015",

language = "English (US)",

volume = "39",

pages = "122",

journal = "Cancer cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "1",

}

TY - JOUR

T1 - Erratum

T2 - Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma (Cancer Cell (2020) 38(4) (500–515.e3), (S1535610820304165), (10.1016/j.ccell.2020.08.005))

AU - Grasso, Catherine S.

AU - Tsoi, Jennifer

AU - Onyshchenko, Mykola

AU - Abril-Rodriguez, Gabriel

AU - Ross-Macdonald, Petra

AU - Wind-Rotolo, Megan

AU - Champhekar, Ameya

AU - Medina, Egmidio

AU - Torrejon, Davis Y.

AU - Shin, Daniel Sanghoon

AU - Tran, Phuong

AU - Kim, Yeon Joo

AU - Puig-Saus, Cristina

AU - Campbell, Katie

AU - Vega-Crespo, Agustin

AU - Quist, Michael

AU - Martignier, Christophe

AU - Luke, Jason J.

AU - Wolchok, Jedd D.

AU - Johnson, Douglas B.

AU - Chmielowski, Bartosz

AU - Hodi, F. Stephen

AU - Bhatia, Shailender

AU - Sharfman, William

AU - Urba, Walter J.

AU - Slingluff, Craig L.

AU - Diab, Adi

AU - Haanen, John B.A.G.

AU - Algarra, Salvador Martin

AU - Pardoll, Drew M.

AU - Anagnostou, Valsamo

AU - Topalian, Suzanne L.

AU - Velculescu, Victor E.

AU - Speiser, Daniel E.

AU - Kalbasi, Anusha

AU - Ribas, Antoni

PY - 2021/1/11

Y1 - 2021/1/11

N2 - (Cancer Cell 38, 500–515.e1–e3; October 12, 2020) In this article, we report that T cell-induced interferon-γ correlates to response to immune checkpoint blockade therapy in melanoma patients. We would like to provide two additional supplemental tables. Table S1 details unidentifiable demographic information of patients to facilitate the re-analysis of the data based on specific patient characteristics or subgroups of melanomas. Table S2 contains the 549 interferon-γ-induced genes in melanoma cell lines that are mentioned in the article. These supplemental tables are now cited in the online version of the article and are provided with this article online.

AB - (Cancer Cell 38, 500–515.e1–e3; October 12, 2020) In this article, we report that T cell-induced interferon-γ correlates to response to immune checkpoint blockade therapy in melanoma patients. We would like to provide two additional supplemental tables. Table S1 details unidentifiable demographic information of patients to facilitate the re-analysis of the data based on specific patient characteristics or subgroups of melanomas. Table S2 contains the 549 interferon-γ-induced genes in melanoma cell lines that are mentioned in the article. These supplemental tables are now cited in the online version of the article and are provided with this article online.

UR - http://www.scopus.com/inward/record.url?scp=85098205365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85098205365&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2020.11.015

DO - 10.1016/j.ccell.2020.11.015

M3 - Comment/debate

C2 - 33306984

AN - SCOPUS:85098205365

SN - 1535-6108

VL - 39

SP - 122

JO - Cancer cell

JF - Cancer cell

IS - 1

ER -

Erratum: Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma (Cancer Cell (2020) 38(4) (500–515.e3), (S1535610820304165), (10.1016/j.ccell.2020.08.005))

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this